Prevalence of Pediatric Masked Hypertension and Risk of Subclinical Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
Authors:
- Jason ChungJCJason Chung
- Cal RobinsonCRCal Robinson
- Lauren SheffieldLSLauren Sheffield
- Prathayini ParamanathanPPPrathayini Paramanathan
- Andrew YuAYAndrew Yu
- Joycelyne EwusieJEJoycelyne Ewusie
- Stephanie SangerSSStephanie Sanger
- Mark MitsnefesMMMark Mitsnefes
- Rulan S. ParekhRPRulan S. Parekh
- Manish D. SinhaMSManish D. Sinha
- Myanca RodriguesMRMyanca Rodrigues
- 1 November 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 80 (11) , 2280-2292
Abstract
Masked hypertension (MH) occurs when office blood pressure is normal, but hypertension is confirmed using out-of-office blood pressure measures. Hypertension is a risk factor for subclinical cardiovascular outcomes, including left ventricular hypertrophy, increased left ventricular mass index, carotid intima media thickness, and pulse wave velocity. However, the risk factors for ambulatory blood pressure monitoring defined MH and its association with subclinical cardiovascular outcomes are unclear. A systematic literature search on 9 databases included English publications from 1974 to 2023. Pediatric MH prevalence was stratified by disease comorbidities and compared with the general pediatric population. We also compared the prevalence of left ventricular hypertrophy, and mean differences in left ventricular mass index, carotid intima media thickness, and pulse wave velocity between MH versus normotensive pediatric patients. Of 2199 screened studies, 136 studies (n=28 612; ages 4–25 years) were included. The prevalence of MH in the general pediatric population was 10.4% (95% CI, 8.00–12.80). Compared with the general pediatric population, the risk ratio (RR) of MH was significantly greater in children with coarctation of the aorta (RR, 1.91), solid-organ or stem-cell transplant (RR, 2.34), chronic kidney disease (RR, 2.44), and sickle cell disease (RR, 1.33). MH patients had increased risk of subclinical cardiovascular outcomes compared with normotensive patients, including higher left ventricular mass index (mean difference, 3.86 g/m 2.7 [95% CI, 2.51–5.22]), left ventricular hypertrophy (odds ratio, 2.44 [95% CI, 1.50–3.96]), and higher pulse wave velocity (mean difference, 0.30 m/s [95% CI, 0.14–0.45]). The prevalence of MH is significantly elevated among children with various comorbidities. Children with MH have evidence of subclinical cardiovascular outcomes, which increases their risk of long-term cardiovascular disease.Keywords
This publication has 72 references indexed in Scilit:
- Ambulatory blood pressure monitoring in chinese children with obstructive sleep apnea/hypopnea syndromePediatric Pulmonology, 2012
- Masked hypertension in young patients after successful aortic coarctation repair: impact on left ventricular geometry and functionJournal of Human Hypertension, 2011
- Masked Hypertension Associates with Left Ventricular Hypertrophy in Children with CKDJournal of the American Society of Nephrology, 2010
- Age-Specific Reference Intervals for Indexed Left Ventricular Mass in ChildrenJournal of the American Society of Echocardiography, 2009
- Tracking of Blood Pressure From Childhood to AdulthoodCirculation, 2008
- A Novel Method of Expressing Left Ventricular Mass Relative to Body Size in ChildrenCirculation, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Left Ventricular Hypertrophy in Hypertensive AdolescentsHypertension, 2007
- White-coat and masked hypertension in children: association with target-organ damagePediatric Nephrology, 2005
- Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: A multicenter trial including 1141 subjectsThe Journal of Pediatrics, 1997